Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped TNXP stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Tonix Pharmaceuticals represents a high-risk, high-reward investment in the volatile biotech space. While recent positive news improves the potential for upside scenarios, significant financial and operational risks persist. Future performance hinges on clinical trial success, regulatory approvals, and the ability to secure non-dilutive funding. The saved 1-year distribution is P10 $9, P50 $16.5, and P90 $25.
Last analyzed · Model: gpt-4o
Tonix Pharmaceuticals Holding Corp. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $9 | Pessimistic plausible scenario |
| P50 | $16.5 | Median scenario |
| P90 | $25 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Tonix Pharmaceuticals has a volatile profile driven by its developmental pipeline and recent positive news; however, its high cash burn rate and recent trial failures pose significant risks.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this TNXP analysis generated?
April 20, 2026.
Is this a guaranteed TNXP prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full TNXP stock analysis · TNXP sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.